BMI1 and laryngeal carcinoma: It has been reported that hsa-miR-128a inhibited tumor proliferation by targeting BMI-1 in prostate cancer [16]; thus, we performed dual luciferase to determine the potential relationship between hsa-miR-128a and BMI-1 in laryngeal cancer cells.